Vice President, Cardiovascular & Metabolic Disease
Sarah Walters is Vice President, US Cardiovascular & Metabolic Diseases (US CVMD). In this role, Sarah leads the overall US CVMD team and is responsible for the strategic direction, selling strategy and performance of the cardiovascular and diabetes business units.
During her 25-year career with AstraZeneca, Sarah has held a variety of leadership roles in both marketing and sales across therapeutic areas and on products in different stages of life cycle. In her most recent position, Sarah served as Country President, Austria where she led the Oncology, Respiratory and Immunology and Cardiovascular Renal Metabolic (CVRM) portfolios. Prior to this, Sarah was the Executive Director, Diabetes Franchise for the US CVMD business unit, where she was responsible for leading the US development and delivery of the strategic and operational commercialization plans across the diabetes portfolio. She also served as the Executive Business Director (EBD) for the CV Specialty Sales Team.
- Bachelor of Science, The Pennsylvania State University
- Master of Business Administration, Wharton School, The University of Pennsylvania
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.